Kerry’s CMD was a positive near-term catalyst, and we now see the opportunity for Kerry to close the growth and valuation gap with peers.
14 Oct 2021
Ambitious, but achievable, new mid-term targets
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Ambitious, but achievable, new mid-term targets
Kerry’s CMD was a positive near-term catalyst, and we now see the opportunity for Kerry to close the growth and valuation gap with peers.